Reduced Immune Activation during Tenofovir-Emtricitabine Therapy in HIV-negative Individuals

BACKGROUND: Elevated immune activation is associated with an increased risk of HIV acquisition. Tenofovir (TFV) has immunomodulatory properties in vitro, but how this extends in vivo remains unknown. METHODS: HIV-negative adults received daily co-formulated tenofovir-disoproxil-fumarate (TDF) 300 mg...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Acquir Immune Defic Syndr
Main Authors: Castillo-Mancilla, Jose R., Meditz, Amie, Wilson, Cara, Zheng, Jia-Hua, Palmer, Brent E., Lee, Eric J., Gardner, Edward M., Seifert, Sharon, Kerr, Becky, Bushman, Lane R., MaWhinney, Samantha, Anderson, Peter L.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4358752/
https://ncbi.nlm.nih.gov/pubmed/25763783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000529
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki